Top Trends Transforming the Onchocerciasis Treatment Market Landscape in 2025: Novel Antiparasitic Medications Driving Growth In The Market Through Improved Efficacy And Access

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Onchocerciasis Treatment Industry Market Size Be by 2025?
In recent times, the market size for onchocerciasis treatment has seen significant growth. It is projected to rise from $1.03 billion in 2024 to $1.11 billion in 2025, with a compound annual growth rate (CAGR) of 7.8%. The growth seen in the past is associated with a surge in patients with eyesight related issues, higher instances of parasitic infections, an expansion in targeted treatment centers, an upswing in informative campaigns, and a burgeoning elderly population.

What's the Long-Term Growth Forecast for the Onchocerciasis Treatment Market Size Through 2029?
The market for onchocerciasis treatment is predicted to experience robust growth in the forthcoming years. Its size is projected to reach $1.48 billion by 2029 with a compound annual growth rate (CAGR) of 7.5%. The anticipated expansion during the forecast period is attributable to an increasing incidence in endemic areas, a growing demand for surgical procedures, improvements in healthcare infrastructure, a rising incidence of chronic conditions, and increased investment in healthcare. The forecast period will likely witness trends such as a move towards single-dose treatments, progress in macrocyclic lactone formulations, the rise of Wolbachia-targeting therapies, the incorporation of artificial intelligence (AI) in drug development, and the creation of treatments specifically designed for children.

View the full report here:
https://www.thebusinessresearchcompany.com/report/onchocerciasis-treatment-global-market-report

What Are the Key Growth Drivers Fueling the Onchocerciasis Treatment Market Expansion?
An increasing number of patients with eye-related ailments are anticipated to drive the expansion of the onchocerciasis treatment market. These eye-related issues can range from infections, injuries, to long-standing diseases like glaucoma or cataracts, all impacting vision and eye health. This increment in eye problems is largely attributed to the rise in screen exposure and lengthy use of digital gadgets. Treatment for onchocerciasis helps in averting and managing vision impairment and blindness in patients by eradicating the parasitic infection responsible for inflammation and damaging the eye tissues. As of May 2024, the Centers for Disease Control and Prevention (CDC), an American public health organization, stated that roughly 20.5 million Americans above the age of 40 had cataracts in one or both eyes, which constitutes 17.2% of this age group. The figure is predicted to reach close to 30 million individuals by 2028. Therefore, this growing rate of eye-related issues contributes to the expanding onchocerciasis treatment market. With the burgeoning need for surgical interventions due to increasing cases which require advanced disease management, the onchocerciasis treatment market is expected to see significant growth. These surgical interventions include healthcare procedures for removing or mending tissues injured by sickness, often relied upon when medicinal treatments prove unsuccessful or pose a threat to long-term health. This need is kindled by the advancement of onchocerciasis in certain patients to severe stages where surgery becomes essential to avert irreversible damage such as vision impairment or facial disfigurement. Consequently, healthcare providers are amplifying surgical services and investing in sophisticated techniques, thereby stimulating the overall onchocerciasis treatment market. According to the International Society of Aesthetic Plastic Surgery (ISAPS), a professional body for certified aesthetic plastic surgeons based in the U.S, nearly 35 million aesthetic procedures were executed globally in 2023, marking a rise of 3.4% from the prior year. The report further underscored that surgical procedures grew by 5.5% involving more than 15.8 million procedures performed by plastic surgeons. Therefore, this growing demand for surgical interventions contributes to the robust growth of the onchocerciasis treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24634&type=smp

What Are the Key Trends Driving Onchocerciasis Treatment Market Growth?
Prominent firms in the onchocerciasis treatment market are concentrating on the creation of new antiparasitic drugs to enhance treatment potency and shorten the treatment period. Antiparasitic medicines are specifically produced to eradicate or restrict parasites such as worms and protozoa, which are responsible for human infections. For instance, in December 2024, the Ghana Food and Drugs Authority (FDA) granted approval to Medicines Development for Global Health (MDGH), a non-profit biopharmaceutical agency based in Australia, for the utilization of Moxidectin 2 mg oral tablets to tackle river blindness in persons aged 4 and above. This endorsement allows Ghana to commence community-oriented mass drug distribution programs using moxidectin, which provides improved efficiency and prolonged effects in comparison to ivermectin. Through this approval, MDGH is aiming to widen the availability of a powerful new onchocerciasis treatment, facilitating large-scale community schemes in affected areas.

How Is the Onchocerciasis Treatment Market Segmented?
The onchocerciasis treatment market covered in this report is segmented -

1) By Drug Type: Ivermectin, Doxycycline, Albendazole, Moxidectin
2) By Treatment Strategy: Mass Drug Administration (MDA), Targeted Treatment
3) By Mode Of Administration: Oral, Injectables, Topical
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals And Clinics, Home Care Settings, Government And Non-Governmental Programs

Subsegments:
1) By Ivermectin: Oral Tablets, Community-Based Mass Drug Administration (MDA) Kits, Fixed-Dose Combination Therapies, Pediatric Formulations
2) By Doxycycline: Oral Capsules, Extended-Release Tablets, Combination With Anti-Wolbachia Therapy, Hospital-Based Prescription Treatments
3) By Albendazole: Single-Dose Oral Tablets, Combination Therapy With Ivermectin, Government-Supplied Preventive Chemotherapy Packages, Over-The-Counter (OTC) Formulations In Endemic Areas
4) By Moxidectin: Oral Tablets, Long-Acting Formulations, Adult-Only Dosing Regimens, Clinical Trial-Based Access Programs

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24634&type=smp

Which Companies Are Leading the Charge in Onchocerciasis Treatment Market Innovation?
Major companies operating in the onchocerciasis treatment market are Merck & Co. Inc., Teva Pharmaceutical Industries Limited, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Intas Pharmaceuticals Limited, Dr. Reddy's Laboratories Inc., Cipla Limited, Endo Inc., Lupin Limited, Instituto de Tecnologia em Imunobiológicos Bio-Manguinhos - Fundação Oswaldo Cruz (Fiocruz), AMGIS Lifescience Ltd., Drugs for Neglected Diseases initiative (DNDi), Raksh*it Drugs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., OREX Pharma Private Limited, Angle Bio Pharma Pvt. Ltd., Senores Pharmaceuticals Inc., Avenacy LLC, Dolphin Pharma, Cerata Pharmaceuticals Inc.

Which Regions Are Leading the Global Onchocerciasis Treatment Market in Revenue?
North America was the largest region in the onchocerciasis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the onchocerciasis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report to*day:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24634

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.